Top news of the week: 28.01.2021.
Career And Jobs
Chutes & Ladders—GSK vaccine exec Reichman splits to take biotech CEO post
Amir Reichman, global vaccines engineering core technology at GSK, is stepping down to pursue a CEO role at BiondVax. Covance's Maryland Franklin is stepping up to run Covance's cell and ...
Biotech Startup Droplet Genomics Raises €1 Million from Practica Capital to Commercialize Droplet Microfluidics Technology
Vilnius, Lithuania, January 27, 2021 – Droplet Genomics, a Lithuanian biotech startup, has today announced that it has raised a total of €1M in a Seed funding round led by Practica Capital, ...
Ten Leading BioPharma Companies Announce Formation of Accumulus Synergy to Develop Global Data Sharing Platform
Ten Leading BioPharma Companies Announce Formation of Accumulus Synergy to Develop Global Data Sharing PlatformFunded by Amgen, Astellas, Bristol Myers Squibb, GSK, Janssen, Lilly, Pfizer, ...
Psychedelic biotech ATAI hopes to expand portfolio through research partnership with Mass General
Psychedelics have made a comeback for mental health research, with companies like startup biotech ATAI Life Sciences raising millions and earning the backing of prominent investors like ...
Infographic: Clinical research career path
How to grow your career in clinical research Clinical research is a competitive but growing field and provides rewarding career opportunities if...
BioSpace Launches 2021 Hotbed Maps to Highlight Thriving Life Sciences Clusters
See the companies featured in our 2021 maps, explore the territories that are thriving in the life sciences industry, research leading employers and search for relevant jobs on BioSpace.
UPDATED: Ex-MD Anderson chief DePinho is helping launch another biotech — and he's sticking with familiar ground
Years after co-founding SINE-focused Karyopharm and stirring up controversy at MD Anderson, Ronald DePinho is helping uncloak a new biotech targeting solute carrier transporter proteins — ...
Scoop: Vivek Ramaswamy is handing the CEO job to a top lieutenant at Roivant — but he’s not exactly leaving the biotech scene
Over the past 7 years since founding Roivant, Vivek Ramaswamy has been a constant blur of biotech building motion. He launched his first biotech with an Alzheimer’s drug he picked up cheap, ...